Trust.med Uses AI to Enhance the Security, Cost, and Safety of the Pharma Supply Chain

There is not a single industry that is not undergoing some kind of transformation in this day and age, and that includes the pharmaceutical industry. But the changes are not all about miracle drugs. The supply chain is another major pain point seeing a potential solution in technology.

Why is that important, though? Well, not only is the pharmaceutical supply chain complex, but there has been a rampant issue with counterfeit drugs that has plagued the industry for quite some time. The use of technology is easing these troublesome problems, with companies like Trust.med incorporating artificial intelligence (AI) into the mix to ensure a seamless, secure, and cost-effective system.

Enhancing Security through Serialization and Verification

As the pharma supply chain grows more intricate, the risks associated with counterfeit drugs have escalated. To counteract these threats, the Drug Supply Chain Security Act (DSCSA) has mandated the creation of mechanisms to enable serialization and traceability.

Trust.med’s Contact and Verification Registry, an AI-driven solution, is at the forefront of this initiative. By developing a centralized registry that is DSCSA-compliant, the company offers a common platform for manufacturers, pharmacies, hospitals, and other authorized trading partners to verify products.

It is the power of AI algorithms that allows for real-time data processing, enhancing the integrity of an otherwise vulnerable supply chain. At the same time, manufacturers can control their drug product information, and pharmacies can easily verify products, which puts a stop to counterfeit drugs before they reach consumers.

Driving Cost Efficiency with Intelligent Automation

While the DSCSA mandated changes to improve security, the guidelines have posed a significant challenge due to the need for interoperability among different systems and programs used by manufacturers, pharmacies, hospitals, and distributors.

An innovative solution pushed forward by Trust.med leverages AI to provide a simplified and unified platform that negates the need for complex system integrations. The intelligent automation accelerates compliance and reduces operational costs.

Additionally, the use of a straightforward API allows easy deployment without the need for new systems or extensive software integrations.

Safeguarding Consumer Safety with Recall Notifications and Accessibility

But the registry created by Trust.med is not limited to professional stakeholders. Instead, it is designed to extend to consumers, offering them the same ability to verify the authenticity of their medications. It is a helpful capability that goes the extra mile to ensure consumer safety.

Moreover, consumers will have better access to recall information. The use of AI allows for rapid response in case of recalls, which involves immediate notifications to pharmacies and other dispensaries. By acting quickly, there is minimal risk of contaminated or harmful drugs reaching patients.

Conclusion

The integration of AI into the pharmaceutical supply chain through platforms like Trust.med’s Contact and Verification Registry exemplifies a modern approach to tackle the ever-growing challenges of security, cost, and consumer safety.

By leveraging intelligent algorithms, the pharma industry is positioned to make significant strides in ensuring compliance with regulations, creating cost-effective solutions, and enhancing patient safety.